ARTICLE | Clinical News
Arimoclomol: Ph II data
January 6, 2017 10:04 PM UTC
A double-blind, placebo-controlled, U.S. and Canadian Phase II trial in 36 patients with rapidly progressive familial ALS due to mutations in the superoxide dismutase 1 (SOD1) gene showed that thrice-...
BCIQ Company Profiles
BCIQ Target Profiles